Skip Navigation
 
 
 
 
Wilmer Eye Institute
 
Print This Page
Share this page: More
 

Nanotechnology and Gene Therapy for Retinopathies

Nanotechnology and Gene Therapy for Retinopathies

Dr. Lutty's Lab is also using nanotechnology to develop unique approaches to treating the retinopathies mentioned in this section.  Many labs are using viruses to deliver genes that can be used to treat diseases.  Viruses, however, can themselves cause problems in that they may initiate inflammation and the genes may be expressed at too high a level or for too long.  Our goal is delivery of therapeutic genes without a virus, using nanoparticles to deliver the genes.  The particles can be made with multiple layers so the outer layer will have a peptide that can target the particles to cells of interest.  A schematic of an iron nanoparticle with multiple layers is seen in Picture 10. These nanoparticles can be delivered to cells in the retina (Picture 11). 

picture 10

Picture 10

Once the particles get into the target cell, the genes are expressed for a limited time period.  Using the genes for naturally occurring antiangiogenic factors, we hope to treat neovascularization without using a virus or a drug.  The nanoparticles can also carry a biosensor DNA that will allow the gene to be expressed only when it is needed.

picture 12

Picture 11

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer